Impaired microRNA processing causes corpus luteum insufficiency and infertility in mice

Journal of Clinical Investigation

Volumn 118, Issue 5, 2008, Pages 1944-1954

  Otsuka, Motoyuki ^a   Zheng, Min ^b   Hayashi, Masaaki ^a,d   Lee, Jing Dwan ^a   Yoshino, Osamu ^c   Lin, Shengcai ^b   Han, Jiahuai ^a,b  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b XIAMEN UNIVERSITY   (China)

^c UNIVERSITY OF TOKYO   (Japan)

^d LEXICON PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; DICER; METALLOPROTEINASE; MICRORNA; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ALLELE; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CAPILLARY; CELL FUNCTION; CONTROLLED STUDY; ENZYME DEFICIENCY; FEMALE; FEMALE INFERTILITY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; LUTEAL INSUFFICIENCY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; RNA PROCESSING;

ALLELES; ANIMALS; BASE SEQUENCE; CORPUS LUTEUM; DEAD-BOX RNA HELICASES; ENDORIBONUCLEASES; FEMALE; INFERTILITY, FEMALE; MALE; MICE; MICE, INBRED C57BL; MICROARRAY ANALYSIS; MICRORNAS; MOLECULAR SEQUENCE DATA; NEOVASCULARIZATION, PHYSIOLOGIC; OVARY; RNA PROCESSING, POST-TRANSCRIPTIONAL; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 42949179661     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI33680     Document Type: Article

References (46)

1. Hannon, G.J. 2002. RNA interference. Nature. 418:244-251.
2. Carmell, M.A., and Hannon, G.J. 2004. RNase III enzymes and the initiation of gene silencing. Nat. Struct. Mol. Biol. 11:214-218.
3. Bartel, D.P. 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 116:281-297.
4. Meister, G., and Tuschl, T. 2004. Mechanisms of gene silencing by double-stranded RNA. Nature. 431:343-349.
5. Jing, Q., et al. 2005. Involvement of microRNA in AU-rich element-mediated mRNA instability. Cell. 120:623-634.
6. Bernstein, E., et al. 2003. Dicer is essential for mouse development. Nat. Genet. 35:215-217.
7. Yang, W.J., et al. 2005. Dicer is required for embryonic angiogenesis during mouse development.
8. Harfe, B.D., McManus, M.T., Mansfield, J.H., Hornstein, E., and Tabin, C.J. 2005. The RNaseIII enzyme Dicer is required for morphogenesis but not patterning of the vertebrate limb. Proc. Natl. Acad. Sci. U. S. A. 102:10898-10903.
9. Muljo, S.A., et al. 2005. Aberrant T cell differentiation in the absence of Dicer. J. Exp. Med. 202:261-269.
10. Cobb, B.S., et al. 2005. T cell lineage choice and differentiation in the absence of the RNase III enzyme Dicer. J. Exp. Med. 201:1367- 1373.
11. Yi, R., et al. 2006. Morphogenesis in skin is governed by discrete sets of differentially expressed microRNAs. Nat. Genet. 38:356-362.
12. Harris, K.S., Zhang, Z., McManus, M.T., Harfe, B.D., and Sun, X. 2006. Dicer function is essential for lung epithelium morphogenesis. Proc. Natl. Acad. Sci. U. S. A. 103:2208-2213.
13. Otsuka, M., et al. 2007. Hypersusceptibility to vesicular stomatitis virus infection in Dicer1-deficient mice is due to impaired miR24 and miR93 expression. Immunity. 27:123-134.
14. Risau, W. 1997. Mechanisms of angiogenesis. Nature. 386:671-674.
15. Adams, R.H., and Alitalo, K. 2007. Molecular regulation of angiogenesis and lymphangiogenesis. Nat. Rev. Mol. Cell Biol. 8:464-478.
16. Poliseno, L., et al. 2006. MicroRNAs modulate the angiogenic properties of HUVECs. Blood. 108:3068-3071.
17. Dews, M., et al. 2006. Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nat. Genet. 38:1060-1065.
18. Kuehbacher, A., Urbich, C., Zeiher, A.M., and Dimmeler, S. 2007. Role of Dicer and Drosha for endothelial microRNA expression and angiogenesis. Circ. Res. 101:59-68.
19. Suarez, Y., Fernandez-Hernando, C., Pober, J.S., and Sessa, W.C. 2007. Dicer dependent microRNAs regulate gene expression and functions in human endothelial cells. Circ. Res. 100:1164-1173.
20. Reynolds, L.P., Grazul-Bilska, A.T., and Redmer, D.A. 2000. Angiogenesis in the corpus luteum. Endocrine. 12:1-9.
21. Reynolds, L.P., Killilea, S.D., and Redmer, D.A. 1992. Angiogenesis in the female reproductive system. FASEB J. 6:886-892.
22. Ferrara, N., et al. 1998. Vascular endothelial growth factor is essential for corpus luteum angiogenesis. Nat. Med. 4:336-340.
23. Nardo, L.G., and Sallam, H.N. 2006. Progesterone supplementation to prevent recurrent miscarriage and to reduce implantation failure in assisted reproduction cycles. Reprod. Biomed. Online. 13:47-57.
24. Jones, G.E. 1949. Some newer aspects of the management of infertility. J. Am. Med. Assoc. 141:1123-1129.
25. Hinney, B., Henze, C., Kuhn, W., and Wuttke, W. 1996. The corpus luteum insufficiency: a multifactorial disease. J. Clin. Endocrinol. Metab. 81:565-570.
26. Pritts, E.A., and Atwood, A.K. 2002. Luteal phase support in infertility treatment: a meta-analysis of the randomized trials. Hum. Reprod. 17:2287-2299.
27. Murchison, E.P., et al. 2007. Critical roles for Dicer in the female germline. Genes Dev. 21:682-693.
28. Tang, F., et al. 2007. Maternal microRNAs are essential for mouse zygotic development. Genes Dev. 21:644-648.
29. Hsieh, M., et al. 2005. Mice null for Frizzled4 (Fzd4-/-) are infertile and exhibit impaired corpora lutea formation and function. Biol. Reprod. 73:1135-1146.
30. Grosdemouge, I., et al. 2003. Effects of deletion of the prolactin receptor on ovarian gene expression. Reprod. Biol. Endocrinol. 1:12.
31. Xu, Q., et al. 2004. Vascular development in the retina and inner ear: control by Norrin and Frizzled-4, a high-affinity ligand-receptor pair. Cell. 116:883-895.
32. Liu, K., Wahlberg, P., Hagglund, A.C., and Ny, T. 2003. Expression pattern and functional studies of matrix degrading proteases and their inhibitors in the mouse corpus luteum. Mol. Cell. Endocrinol. 205:131-140.
33. Reynolds, L.P., Grazul-Bilska, A.T., and Redmer, D.A. 2002. Angiogenesis in the female reproductive organs: pathological implications. Int. J. Exp. Pathol. 83:151-163.
34. Rusinov, V., Baev, V., Minkov, I.N., and Tabler, M. 2005. MicroInspector: a web tool for detection of miRNA binding sites in an RNA sequence. Nucleic Acids Res. 33:W696-W700.
35. Miranda, K.C., et al. 2006. A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes. Cell. 126:1203-1217.
36. John, B., et al. 2004. Human MicroRNA targets. PLoS Biol. 2:e363.
37. Lewis, B.P., Shih, I.H., Jones-Rhoades, M.W., Bartel, D.P., and Burge, C.B. 2003. Prediction of mammalian microRNA targets. Cell. 115:787-798.
38. Akahane, T., et al. 2004. TIMP-1 inhibits microvascular endothelial cell migration by MMP-dependent and MMP-independent mechanisms. Exp. Cell Res. 301:158-167.
39. Handsley, M.M., and Edwards, D.R. 2005. Metalloproteinases and their inhibitors in tumor angiogenesis. Int. J. Cancer. 115:849-860.
40. Khokha, R., Zimmer, M.J., Graham, C.H., Lala, P.K., and Waterhouse, P. 1992. Suppression of invasion by inducible expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) in B16-F10 melanoma cells. J. Natl. Cancer Inst. 84:1017-1022.
41. Madri, J.A., Pratt, B.M., and Tucker, A.M. 1988. Phenotypic modulation of endothelial cells by transforming growth factor-beta depends upon the composition and organization of the extracellular matrix. J. Cell Biol. 106:1375-1384.
42. Matzuk, M.M., and Lamb, D.J. 2002. Genetic dissection of mammalian fertility pathways. Nat. Cell Biol. 4:s41-s49.
43. Wang, H., and Dey, S.K. 2006. Roadmap to embryo implantation: clues from mouse models. Nat. Rev. Genet. 7:185-199.
44. Roy, A., and Matzuk, M.M. 2006. Deconstructing mammalian reproduction: using knockouts to define fertility pathways. Reproduction. 131:207-219.
45. Inzunza, J., et al. 2007. Ovarian wedge resection restores fertility in estrogen receptor beta knockout (ERbeta-/-) mice. Proc. Natl. Acad. Sci. U. S. A. 104:600-605.
46. Oliver, G.W., Leferson, J.D., Stetler-Stevenson, W.G., and Kleiner, D.E. 1997. Quantitative reverse zymography: analysis of picogram amounts of metalloproteinase inhibitors using gelatinase A and B reverse zymograms. Anal. Biochem. 244:161-166.